BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32504922)

  • 21. Regulation of cancer cell death by a novel compound, C604, in a c-Myc-overexpressing cellular environment.
    Jo MJ; Paek AR; Choi JS; Ok CY; Jeong KC; Lim JH; Kim SH; You HJ
    Eur J Pharmacol; 2015 Dec; 769():257-65. PubMed ID: 26607468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEF2D-BCL9 B-Lymphoblastic Leukemia Blast Morphology Does Not Always Mimic Mature B-Cell Leukemia.
    Baek HJ; Choi YJ; Kim BR; Lee JH; Shin MG; Kook H
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):112-113. PubMed ID: 33235148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-translational modification of cyclin A1 is associated with staurosporine and TNFalpha induced apoptosis in leukemic cells.
    Ekberg J; Persson JL
    Mol Cell Biochem; 2009 Jan; 320(1-2):115-24. PubMed ID: 18787932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells.
    Xie S; Jiang H; Zhai XW; Wei F; Wang SD; Ding J; Chen Y
    Acta Pharmacol Sin; 2016 Nov; 37(11):1481-1489. PubMed ID: 27569395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lycium barbarum polysaccharides attenuates N-methy-N-nitrosourea-induced photoreceptor cell apoptosis in rats through regulation of poly (ADP-ribose) polymerase and caspase expression.
    Zhu Y; Zhao Q; Gao H; Peng X; Wen Y; Dai G
    J Ethnopharmacol; 2016 Sep; 191():125-134. PubMed ID: 27208869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential mechanisms of resistance to venetoclax and strategies to circumvent it.
    Tahir SK; Smith ML; Hessler P; Rapp LR; Idler KB; Park CH; Leverson JD; Lam LT
    BMC Cancer; 2017 Jun; 17(1):399. PubMed ID: 28578655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PKC412 induces apoptosis through a caspase-dependent mechanism in human keloid-derived fibroblasts.
    Nakazono-Kusaba A; Takahashi-Yanaga F; Miwa Y; Morimoto S; Furue M; Sasaguri T
    Eur J Pharmacol; 2004 Aug; 497(2):155-60. PubMed ID: 15306200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways.
    Zhang XD; Gillespie SK; Hersey P
    Mol Cancer Ther; 2004 Feb; 3(2):187-97. PubMed ID: 14985459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
    Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
    Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staurosporine resistance in inflammatory neutrophils is associated with the inhibition of caspase- and proteasome-mediated Mcl-1 degradation.
    Hornstein T; Lehmann S; Philipp D; Detmer S; Hoffmann M; Peter C; Wesselborg S; Unfried K; Windolf J; Flohé S; Paunel-Görgülü A
    J Leukoc Biol; 2016 Jan; 99(1):163-74. PubMed ID: 26310832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.
    Yuan N; Song L; Zhang S; Lin W; Cao Y; Xu F; Fang Y; Wang Z; Zhang H; Li X; Wang Z; Cai J; Wang J; Zhang Y; Mao X; Zhao W; Hu S; Chen S; Wang J
    Haematologica; 2015 Mar; 100(3):345-56. PubMed ID: 25512644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
    Sun J; Yu W; Zhang X
    Ann Hematol; 2020 Jan; 99(1):185-188. PubMed ID: 31781846
    [No Abstract]   [Full Text] [Related]  

  • 34. High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines.
    Akahane K; Yasuda T; Tsuzuki S; Hayakawa F; Kiyokawa N; Somazu S; Watanabe A; Kagami K; Abe M; Harama D; Goi K; Kawazu M; Kojima S; Imamura T; Goto H; Iwamoto S; Minegishi M; Abe M; Hojo H; Inaba T; Mano H; Sugita K; Inukai T
    Hematol Oncol; 2020 Oct; 38(4):614-617. PubMed ID: 32515032
    [No Abstract]   [Full Text] [Related]  

  • 35. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
    Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
    Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo.
    Yuan SY; Cheng CL; Ho HC; Wang SS; Chiu KY; Su CK; Ou YC; Lin CC
    Eur J Pharmacol; 2015 Aug; 761():309-20. PubMed ID: 26086857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with
    Uchida A; Isobe Y; Asano J; Uemura Y; Hoshikawa M; Takagi M; Miura I
    Haematologica; 2019 Jul; 104(7):1417-1421. PubMed ID: 30523053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
    Sampson A; Peterson BG; Tan KW; Iram SH
    Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1.
    Teh TC; Nguyen NY; Moujalled DM; Segal D; Pomilio G; Rijal S; Jabbour A; Cummins K; Lackovic K; Blombery P; Thompson E; Ekert PG; Lessene G; Glaser SP; Huang DCS; Roberts AW; Guthridge MA; Wei AH
    Leukemia; 2018 Feb; 32(2):303-312. PubMed ID: 28751770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
    Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.